论文部分内容阅读
目的探讨改良森田疗法对住院精神分裂症康复治疗的效果。方法采用随机抽样方法把64例住院精神分裂症患者分为实验组和对照组各32例,在治疗前和治疗10周末时用简明精神病评定量表(BPRS)、阴性症状评定量表(SANS)、临床疗效总评量表(CGI-GL)进行疗效评定。于治疗前及10周末用生活质量综合评定问卷(GQOLI-74)评定生活质量。结果两组于第10周末BPRS、SANS、CGI-GL评分降低,与治疗前比较具有统计学意义,实验组(t=9.09,9.95,9.17;P<0.01),对照组(t=5.65,4.15,4.07;P<0.01),但实验组改善程度明显优于对照组(t=4.77,5.66,4.98;P<0.01)。两组在治疗10周后GQOLI-74各因子(社会功能维度、物质生活维度、心理功能维度、躯体功能维度)与治疗前比较有改善:实验组(t=5.45,10.36,10.54,21.69;P<0.01),对照组(t=3.66,5.07,6.65,8.62;P<0.01),但实验组改善程度明显优于对照组(t=2.97,5.20,4.40,11.27;P<0.01)。结论改良森田疗法能进一步改善住院精神分裂症患者的精神症状,并且能显著提高患者的生活质量,促进社会康复。
Objective To explore the effect of modified Morita therapy on hospitalized schizophrenia rehabilitation. Methods Sixty-four inpatients with schizophrenia were divided into experimental group and control group by random sampling method. The levels of BPRS, SANS, , Clinical efficacy of total rating scale (CGI-GL) for efficacy evaluation. Quality of life was assessed before and at the end of the 10 weeks using the Quality of Life Questionnaire (GQOLI-74). Results The scores of BPRS, SANS and CGI-GL in the two groups decreased at the end of the 10th week, which were significantly different from those before treatment (t = 9.09,9.95,9.17; P <0.01) , 4.07; P <0.01), but the improvement in the experimental group was significantly better than that in the control group (t = 4.77,5.66,4.98; P <0.01). After 10 weeks of treatment, GQOLI-74 factors (social function dimension, material life dimension, psychological function dimension and somatic function dimension) in both groups were improved compared with before treatment: experimental group (t = 5.45,10.36,10.54,21.69; P (T = 3.66,5.07,6.65,8.62; P <0.01), but the improvement in the experimental group was significantly better than that in the control group (t = 2.97,5.20,4.40,11.27; P <0.01). Conclusion Modified Morita therapy can further improve the psychiatric symptoms of inpatients with schizophrenia, and can significantly improve the quality of life of patients and promote social rehabilitation.